← Back to Search

Implant

Baerveldt 350 implant for Glaucoma

N/A

Waitlist Available

Led By Leon Herndon, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up year 1

Awards & highlights

Study Summary

This trial will compare the outcomes of two different types of eye surgery. One surgery uses the Baerveldt implant and the other uses the Ahmed ClearPath implant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ year 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~year 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and year 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in intraocular pressure (IOP)

Complication rate

Secondary outcome measures

Change in Best corrected visual acuity (BCVA)

Change in Dilated fundus exam (DFE)

Change in Humphrey visual field (HVF)

+12 more

Trial Design

2Treatment groups

Active Control

Group I: Baerveldt 350 implantActive Control1 Intervention

Group II: Ahmed ClearPath 350 implantActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,356 Previous Clinical Trials

3,418,918 Total Patients Enrolled

13 Trials studying Glaucoma

2,730 Patients Enrolled for Glaucoma

Leon Herndon, MDPrincipal InvestigatorDuke University

3 Previous Clinical Trials

198 Total Patients Enrolled

2 Trials studying Glaucoma

100 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can new participants still register for this clinical experiment?

"This medical trial, initially posted on December 17th 2020 and recently updated on July 13th 2022, is not currently enrolling any new patients. Nevertheless, there are 206 other trials actively seeking participants presently."

Answered by AI

Is the demographic of this trial limited to only individuals under 80 years old?

"This trial is looking for volunteer participants who are of at least 18 years of age and below the age of 90."

Answered by AI

Is there a possibility I can take part in this clinical experiment?

"This clinical trial is inviting up to 76 eligble persons with glaucoma, aged 18-90 years old. Additionally, the participants must meet a series of criteria: gender (male or female), inadequately managed glaucoma, lack of valve in their eye's aqueous shunt for surgery, primary glaucomas/pseudoexfoliation/pigmentary/traumatic glaucomas that have failed trabeculectomy or other intraocular surgeries previously attempted; superotemporal or inferonasal placement of tube and be competent enough to provide consent."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Baerveldt Versus ClearPath Comparison Study

2020. "The Baerveldt Versus ClearPath Comparison Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04468633.